Millennium Biotechnologies, Inc. (OTCBB:MBTG), a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements for the medical market, today announced preliminary results of its second double blind, placebo controlled clinical trial that found its Resurgex(R) nutritional formula provided improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat in Rutgers University Division 1 football players (strength athletes). The preliminary results showed Resurgex(R) out performed a leading sports nutritional formula commonly used by athletes. This emerging new data, coupled with the first trial that found its Resurgex(R) nutritional formula provided enhanced performance parameters and reduced oxidative stress levels (free radical damage caused by exercise) in Rutgers University Division 1 soccer players (endurance athletes), further suggests an important role for Resurgex in the sports fitness field.
